NUCARD

This brand name is authorized in Nigeria.

Active ingredients

The drug NUCARD contains one active pharmaceutical ingredient (API):

1	Valsartan UNII 80M03YXJ7I - VALSARTAN
	Valsartan is an orally active, potent, and specific angiotensin II (Ang II) receptor antagonist. It acts selectively on the AT1-receptor subtype, which is responsible for the known actions of angiotensin II.
	Read more about Valsartan

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-9621	Tablet	Nucard 160 mg Tablet TAB 160 mg 4 x 7's (in Alu-Alu blisters)	Film-coated Tablet Blue colored, round, biconvex film-coated tablet having bisect line on one side and plain from both sides	25/09/2024
B4-9622	Tablet	Nucard 80 mg Tablet TAB 80 mg 4 x 7's (in Alu-Alu blisters)	Film-coated Tablet. Light yellow, oval, bi-convex, film coated tablet having bisect line on one side and plain from both sides	18/12/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C09CA03	Valsartan	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09C Angiotensin II antagonists, plain → C09CA Angiotensin II antagonists, plain
Discover more medicines within C09CA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-9621, B4-9622